Alagille Syndrome (ALGS)

Also known as: Alagille Syndrome / Arteriohepatic dysplasia (disorder)

DrugDrug NameDrug Description
DB16226MaralixibatAn ileal bile acid transporter inhibitor indicated to treat cholestatic pruritus in patients with Alagille syndrome.
DB16261OdevixibatAn ileal sodium/bile acid cotransporter inhibitor indicated in the treatment of pruritus in patients with progressive familial intrahepatic cholestasis.
DrugDrug NamePhaseStatusCount
DB01432Cholestyramine1Completed1
DB16261Odevixibat1Completed2
DB16226Maralixibat2Active Not Recruiting1
DB16226Maralixibat2Completed5
DB16226Maralixibat3Active Not Recruiting1
DB16261Odevixibat3Active Not Recruiting1
DB16261Odevixibat3Completed1
DB01076Atorvastatin4Recruiting1
DB13749Magnesium gluconateNot AvailableCompleted1
DB00653Magnesium sulfateNot AvailableCompleted1
DB16226MaralixibatNot AvailableApproved for Marketing1
DB16226MaralixibatNot AvailableRecruiting1